is tirzepatide safe for hypothyroidism and Tirzepatide: Safety & Efficacy Tirzepatide for Hashimoto's Disease: Evidence

Conclusion As weve explored throughout this post, the effectiveness of GLP-1 receptor agonists can vary significantly among individuals

They're designed to: Confirm the weight loss and metabolic benefits seen in Phase 2 Identify rare side effects that smaller trials might have missed Demonstrate consistent results across diverse populations (age, sex, ethnicity, comorbidities) Build long-term safety data (cardiovascular outcomes, liver health, kidney function) Provide the evidence package the FDA needs to approve the drug Retatrutide's Phase 2 results were strong enough (up to 24.2% weight loss) that Eli Lilly moved it into a large Phase 3 program

doi:10.1038/s41392-024-01931-z Hui H, Farilla L, Merkel P, Perfetti R

Accessed March 23, 2023

Read the label to confirm youre using the right medicine and that it hasnt expired

"So many of my patients were on it, and I wanted to see what it was like when you're not diabetic and you only have 10-15 pounds to lose," he said